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S U M M A R Y
In 2012, more than 80,000 cases of HIV infection were recorded in the Southern Chinese minority
autonomous region of Guangxi Zhuang, where the occurrence of HIV-associated dementia remains high.
The International HIV Dementia Scale is a relatively simple-to-administer screening scale for HIV-
associated neurocognitive disorders. However, clinical experience in utilizing the scale with large
Chinese samples is currently lacking, especially among individuals with limited formal schooling. In this
study, a full neuropsychological evaluation the gold standard was conducted to identify the incidence/
prevalence of HIV-associated neurocognitive disorders in a socioeconomically underdeveloped region of
Southern China and to locate the optimal cut-off scale value using receiver operating characteristic
curves. The highest Youden index of the scale was 0.450, with a corresponding cut-off point of 7.25. The
sensitivity and speciﬁcity were 0.737 and 0.713, respectively. These results suggest that the scale is an
effective and feasible screening tool for HIV-associated neurocognitive disorders in poorer regions of
China with fewer well-educated residents.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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HIV-associated neurocognitive disorders (HAND) remain prev-
alent, especially in regions like Guangxi Zhuang, a minority
autonomous region in Southern China, where the total number of
infections was estimated to be over 80,000 in 2012. Although the
incidence of HIV dementia (HAD) has been halved with the use of
antiretroviral therapy (ART), its prevalence remains high. There-
fore, appropriate brief screening tools are needed in order to
facilitate the timely initiation of HAD treatment. The International
HIV-associated Dementia Scale (IHDS) was developed in 1995 to
screen for HAND1, and many studies since 2005 have shown the
effectiveness of this scale as a screening tool and have demon-
strated its satisfactory sensitivity and speciﬁcity in a variety of
populations.* Corresponding author. Public Health College of Guangxi Medical University,
Shuangyong Road 22, Nanning, Guangxi Medical University, China 530021.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).For example, the sensitivity and speciﬁcity of the scale were
recorded at 80% and 55% for a Ugandan sample.2–5 In both
American and Spanish-speaking populations,3–6 the IHDS was also
shown to be an effective tool in screening for HIV-associated
dementia. Because of its relative ease of use, the IHDS may be
applied in regions of Europe and Africa where English is not the
ﬁrst language. According to Antinori, who further studied and
revised the HIV Dementia Scale (HDS) and the IHDS, the latter can
be used in place of standard neuropsychological tests typically
used to diagnose HAND, especially in areas where resources are
limited, such as developing countries like Africa and China7.
However, the outcomes of psychological testing tools are
inﬂuenced by a range of cultural, linguistic, and regional factors.
Validity must be demonstrated in relation to the speciﬁc
sociocultural environments in which the individuals who are
screened with these instruments live. Thus far, the sensitivity and
speciﬁcity of HAND screening tools such as the IHDS have not been
reported for China’s vast population. Few studies have examined
the administration or use of this scale in a predominantly Chinese-
speaking society. As previous research has demonstrated that the
results of cognitive function tests may be inﬂuenced by theciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Figure 1. Flow chart of screening process
*Additional MRI (n = 88) and CSF (n = 79) examinations, who was suspected to need
them.
#12 neuropsychological tests: The Digit Span Test and Trail Making Part A,
Attachment; Immediate Visual and Visual Delayed Memory; Vocabulary and
Concept Fluency; Digital Symbols, Wood Puzzles, and Total Arithmetic Scores; and
the Stroop Test and the Wisconsin Classiﬁcation Test.
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instruments may vary depending on associated factors, such as the
educational levels of the screened individuals.
One of the researchers of the present study, TingTing Zhao, and
her research team found 200 cases of HIV infection in 2011 while
researching its prevalence in the mountains of Southwest China.9
When the results were analyzed while controlling for educational
background, the diagnostic cut-off score of the IHDS appeared to be
8.25. However, when sociocultural differences or inﬂuences were
factored in, the prevalence of infection in groups of individuals
with different educational levels varied, with different diagnostic
cut-off values being identiﬁed for each group. Analyzing the IHDS
scores of those who had a high school, secondary school, or higher
level of education, Zhao and her colleagues found that the scale’s
diagnostic cut-off was 8.25, whereas this value was 7.25 for
individuals with a primary school education.9
These results caused us to question the use of a single cut-off
point in screening individuals for HAND using the IHDS. More
speciﬁcally, we were curious about (1) the scale’s efﬁcacy in
screening for HAND in a Chinese population, (2) its optimal cut-off
point when used to screen for HAND in individuals with low levels
of education, and (3) whether the IHDS is more efﬁcient in
screening for HAND compared to established scales such as the
Mini Mental State Examination (MMSE).
This study thus evaluated the diagnostic cut-off of the IHDS in
screening for HAND in the multi-ethnic minority autonomous
region of Guangxi Zhuang in Southern China, where economic and
educational development lag behind those of many of China’s
other regions. Several studies have shown that although the MMSE
is sensitive to cortical dementia, it is only 50% sensitive to
diagnosing subcortical dementia, such as AIDS-related dementia.1
However, the MMSE has been used for many years in China and is
the most commonly used cognitive screening tool by clinicians.
Our study, therefore, sought to compare the diagnostic values of
both the IHDS and MMSE in a large sample of Chinese individuals
whose educational levels were lower than those of residents/
populations of China’s more developed regions.
2. Methods
2.1. Subjects
This study was part of a larger study on HAND conducted in the
Guangxi Zhuang autonomous region of Southern China. To
summarize, the potential research sample (n = 345, age 18–65
years) was recruited from three health care centers (the Fourth
People’s Hospital of Nanning, Guangxi Longtan Hospital and the
First afﬁliated hospital of Guangxi Medical University) providing
medical services to HIV infected patients. Data collection took
place between February 2011 and August 2012. The ﬁnal research
sample, consisted of 230 HIV-infected patients (Figure 1: Flow
chart of screening process). We used the following criteria for
exclusion from our HIV/AIDS population: (1)Severe physical
disease preventing the completion of the study;(2)Nervous system
diseases that might lead to cognitive function decline, such as
nervous system opportunistic infections, intracranial tumors,
history of head trauma, and cerebrovascular diseases;(3)Severe
depression, anxiety, or other mental illness affecting cognitive
functioning; (4) Other systematic diseases that could damage
cognitive functioning, such as thyroid dysfunction; (5) Those
whose CSF syphilis antibodies were positive (+) and/or who were
unwilling to cooperate with the lumbar puncture; and (6) Presence
of achromatopsia or hypochromatopsia.
All participants attended two full study sessions, during which
detailed sociodemographic, neuromedical, neuropsychological,
and laboratory measures were administered. The evaluations tooktwo to three hours and were conducted by trained technicians in
the participants’ ﬁrst language. All subjects received CT screening
in the ﬁrst round, and further testing, including cranial magnetic
resonance imaging (MRI) (n = 88), CSF, was administered to any
patient who was suspected to suffer from cognitive dysfunction
(n = 79). However, due to the limitations of their medical
conditions, not all patients evidenced cognitive dysfunction via
MRI and CSF examinations. Before administering the tests, we
administered the Hamilton Depression Scale, the Self-rating
Anxiety Scale, and the Activities of Daily Living Scale to eliminate
participants with severe depression, severe anxiety, and severe
impairments in functioning due to psychiatric disorders, substance
abuse, or signiﬁcant neurological disorders.
After participants were diagnosed and classiﬁed into one of four
HAND categories, the possibility of cognitive dysfunction or other
brain diseases was ruled out for all of them through a CT
examination, in accordance with the updated criteria established
through recent research by Antinori et al.10 In other words, none of
the participants showed any sign of asymptomatic neuropsycho-
logical impairment (ANI) or mild neurocognitive disorder (MND).
All participants who met the study criteria and who agreed to
participate provided their written informed consent before they
were screened with the IHDS/MMSE and the neuropsychological
test battery. Approval to conduct the study was obtained from the
Research Ethics Committee of Guangxi Medical University and the
relevant clinical authorities.
2.2. Neuropsychological test battery
A neuropsychological test battery was administered to all
participants to assess speciﬁc domains of neurocognitive functio-
ning(n = 230). The battery consisted of 12 neuropsychological tests
covering the Digit Span Test and Trail Making Part A, Attachment;
Table 1
Test-Retest Reliability of the IHDS and Its Items
Statistical measure IHDS Item 1 Item 2 Item 3
Pearson’s correlation coefﬁcient 0.955 0.947 0.910 0.783
P value 0.000 0.000 0.000 0.000
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Concept Fluency; Digital Symbols, Wood Puzzles, and Total
Arithmetic Scores; and the Stroop Test and the Wisconsin
Classiﬁcation Test. Control data for neuropsychological testing
were obtained from 99 HIV-negative participants who were the
patients’ healthy family members or accompanying persons who
tested negative on HIV antibody tests within three months of the
study. The control and patient groups did not differ in four areas:
age, sex, years of education, and income.
To determine neurocognitive disorder status, we used the
above-mentioned neuropsychological test battery and an evalua-
tion of functional assessment the Patient’s Assessment of Own
Functioning Inventory (PAOFI) and the Quality of Life and
Enjoyment Satisfaction Questionnaire (QLESQ). Participants were
classiﬁed into one of four HAND categories. Individuals who scored
more than two standard deviations (SDs) below the mean on at
least two domains of function and were noted to have signiﬁcant
functional impairment on self-reports were classiﬁed as having
HAD. Those who displayed impairment between one and two SDs
below the mean were classiﬁed as having either MND or ANI,
depending on the presence or absence of functional impairment.
The remaining participants were classiﬁed as non-impaired. The
ﬁnal classiﬁcation was conducted by two HIV neuropsychiatrists
and a neurologist.
2.3. Statistical analysis methods
Data were analyzed using SPSS 17.0. Homogeneity of variance
data was described in terms of the mean and standard deviation,
which were obtained through analyses of variance and covariance,
as well as a comparison of the means. Heterogeneity of variance
data was described in terms of the median and interquartile ranges
using the rank-sum test. Correlation analyses were performed
along with co-correlation analysis.
3. Results
3.1. HIV-related neurocognitive disorder detection rate
This study recruited 329 participants: 99 controls and 230 HIV/
AIDS patients. According to the diagnostic criteria of the American
Academy of Neurology, a neurologist or a psychological consultant
with AIDS nervous system symptom expertise found that 144
(62.60%) HIV-positive patients were without cognitive impairment
(UN), and 86 (37.39%) were diagnosed with HAND, including
42 cases of ANI (18.27%), 25 cases of MND (10.87%), and 19 cases of
HIV-related dementia (8.26%).
3.2. Test-retest reliability of the IHDS and its items
Test-retest reliability was evaluated using correlation results
from Pearson correlation tests performed twice with the same
patients within a one-week interval. Surveying errors caused by
variations in time or occasion on the two tests indicated testing
needed to be implemented within the span of a week. The results
are detailed in Table 1. The IHDS and all of its items had good test-
retest correlations. Coefﬁcients were greater than 0.75, and
correlation hypothesis test P values were less than 0.01. The IHDS
total score retest results were the most stable. This correlation
coefﬁcient (0.955) was the highest, which suggested greater
stability.
The last item on the scale assessed memory recall, whereby
patients were asked to recall four words. For words that were not
recalled, patients were given prompts containing semantic clues,
such as animal (for ‘‘dog’’), piece of clothing (for ‘‘hat’’), vegetable
(for ‘‘bean’’), and color (for ‘‘red’’). They were given 1 point for eachword spontaneously recalled and 0.5 points for each correct
answer after prompting. The test-retest reliability of this item was
the least stable of all the items on the IHDS, as it had the lowest
correlation coefﬁcient (0.783).
3.3. Homogeneity reliability of the IHDS
Cronbach’s a coefﬁcient was used to rate the scale’s internal
consistency. The scale’s reliability coefﬁcient was 0.580, indicating
that there was unsatisfactory homogeneity bias. Additionally,
observations regarding the statistical impact of each item and
changes in the mean total score and variance were made via
Spearman’s correlation coefﬁcient sensitivity analyses for each
entry when the item was removed. As shown in Table 2, when
Questions 1, 2, and 3 were removed, Cronbach’s a coefﬁcients were
0.348, 0.273, and 0.656, respectively.
3.4. Analysis of the validity of the IHDS
The scale’s total score, as well as the three individual items, was
compared using the F-test in the normal control (HIV-), HIV-
positive without cognitive impairment (UN), HIV-associated ANI,
HIV-associated MND, and HIV-associated dementia (HAD) groups.
The total score of the IHDS and each of its items (P < 0.05) were
signiﬁcantly different, suggesting the scale was able to differenti-
ate among the different types of HIV dementia. However,
comparisons within each group showed that the IHDS did not
distinguish well between varying degrees of severity of HIV-
associated dementia. Table 3 displays the concrete test results.
3.5. Diagnostic efﬁciency evaluations of the MMSE and IHDS
The receiver operating characteristic (ROC) curves for the IHDS
and MMSE were drawn from clinical ﬁndings, as well as from data
from a battery of neuropsychological tests, the gold standard for
HAD evaluations (see Figure 2). The areas under the curves were
0.687 and 0.772 when the MMSE and IHDS were used to diagnose
the HAD and normal groups. The results suggested that the IHDS
possessed stronger diagnostic capabilities than did the MMSE.
Our study also identiﬁed the scale’s sensitivity and speciﬁcity
and the Youden index demarcation point within the scope. Table 4
reveals the maximum Youden indexes that were selected as
optimal cut-off points for distinguishing the HAD and normal
groups using both scales. The highest Youden index of the IHDS
was 0.450, with a corresponding cut-off point of 7.25. The
sensitivity and speciﬁcity were 0.737 and 0.713, respectively.
The highest Youden index of the MMSE was 0.358, and its
corresponding cut-off point was 24.5. The sensitivity and
speciﬁcity were 0.474 and 0.884, respectively. In the analysis of
the HIV-positive group that included the selection of cut-off points,
one decimal was kept, so that the diagnostic cut-off value of the
IHDS for the normal group was estimated to be greater than 7.3.
3.6. IHDS scores of AIDS patients with different characteristics
IHDS scores of AIDS patients with different characteristics are
shown in Table 4. There was a signiﬁcant difference between
patients who were aged 60 years or above and those below age
60. In addition, there were signiﬁcant differences between Zhuang
Table 2
Analysis of the Sensitivity of the IHDS and Its Items
Item Scale mean
after this item
was removed
Scale variance
after this item
was removed
Total correlation
coefﬁcient of
correcting entries
Multiple regression
coefﬁcient squared
Cronbach’s a coefﬁcients
after this item was
removed
IHDS FT subscore 5.69 2.028 0.474 0.255 0.348
IHDS hand sequence subscore 5.83 1.366 0.516 0.281 0.273
IHDS 4-word recall 4.46 3.088 0.246 0.065 0.656
Table 3
Comparison of IHDS Total Scores and Individual Item Scores by Participant Group
Item HIV(n = 99) UN (n = 144) ANI (n = 42) MND (n = 25) HAD (n = 19) P value Comparison between
groups*
IHDS score 10.02  1.08 8.22  1.93 8.06  1.94 7.62  1.88 6.53  2.23 0.000 1>2 = 3 = 4>5
IHDS FT subscore 3.24  0.48 2.44  0.88 2.12  0.80 2.04  1.02 2.05  0.85 0.000 1>2>3 = 4 = 5
IHDS hand sequence subscore 3.31  0.55 2.19  1.11 2.38  1.15 2.00  1.16 1.63  1.17 0.000 1>2 = 3 = 4>5
IHDS 4-word recall 3.58  0.50 3.61  0.51 3.54  0.56 3.58  0.66 2.84  1.03 0.000 1 = 2 = 3 = 4>5
* 1 for HIV-, 2 for UN, 3 for ANI, 4 for MND, 5 for HAD.
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patients who graduated from junior high school and those who did
not (t = -5.754, P = 0.000). However, there were no signiﬁcant
differences between the genders or between patients who smoked
and drank alcohol excessively and those who did not (P > 0.05).
4. Discussion
The IHDS is a convenient and effective screening tool for HAND
as it has the following characteristics: (1) It was especially
developed for subcortical dementia, including HIV/AIDS-related
dementia. This considers not only psychomotor and executive
ability, but also information processing and language ability; (2)
The IHDS, which consists of three main entries assessing four
aspects, including memory registration, motor speed, psychomo-
tor speed, and memory recall, is simple and easy enough for non-
professionals to implement; (3) As its content basically avoids
language and cultural differences, the IHDS can be usedFigure 2. ROC curves of MMSE and IHDS scores.worldwide; and (4) The sensitivity and speciﬁcity of the IHDS
are relatively higher than are those of other HAND measures.
Previous studies reporting on the screening performance of the
IHDS have noted that its scientiﬁc and rational design make it easy
to understand and operate. Due to its relative ease of use, it can be
applied in Europe and some African regions where English is not
the ﬁrst language. The ﬁndings of our study conﬁrm that the scale
is an economical, efﬁcient, and well-performing screening tool
suitable for use in China.
Generally, scale reliability is considered good when the
reliability index is greater than 0.7. The entire scale’s test-retest
reliability was an optimal 0.949 in this study. The test-retest
reliability of items 1, 2, and 3 were 0.940, 0.894, and 0.743,
respectively. The test-retest reliability of the entire scale was
optimal, but the third item demonstrated less stability than the
ﬁrst two. While the test-retest reliability of each item was better
than the scale’s homogeneous reliability of 0.580, the third item’s
test-retest reliability was relatively low.
There are several possible reasons for this low index. First is the
reliability coefﬁcients of the scale are related to the number of
items it contains; the greater the number of items, the larger the
reliability coefﬁcients. Because the IHDS had only three items, its
reliability coefﬁcient was low. Second, items included in the
analyses of the scale’s sensitivity may have also had an impact on
reliability coefﬁcients. In this study, we found that if we removed
the ﬁrst and second entries, the homogeneity reliability coefﬁcient
was reduced, but when we deleted the third entry from the scale,
the scale’s homogeneity reliability coefﬁcient rose markedly, from
0.580 up to 0.656. This suggests that the third item may be an
important factor that needs to be explored in greater depth.
The results of the discriminant validity analysis revealed
signiﬁcant differences among all the study participant groups,
which indicates that the scale’s discriminant validity is acceptable.
Although the IHDS and MMSE can both be used to screen for HAND
across different languages, cultures, and education levels, the IHDS
demonstrates better screening capacity compared to the MMSE in
our study. Possible explanations for this ﬁnding may lie in the fact
that the IHDS was especially designed to screen for HIV/AIDS
cortical dementia. Second, the IHDS considers not only psycho-
motor and executive functioning but also subjects’ learning and
information processing capabilities. The IHDS also contains less
content, screening subjects through only 3 items/entries on
‘‘memory registration,’’ ‘‘psychomotor speed,’’ and ‘‘memory
recall.’’ In contrast, the MMSE consists of 30 entries, and its
contents are more difﬁcult to administer, normally taking about
20–30 minutes to complete.
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shows a higher degree of sensitivity, speciﬁcity, and accuracy in
screening for HAND than does the MMSE. Studies on similar
populations have indicated that the IHDS has better sensitivity and
speciﬁcity than the MMSE. Power et al.1 used the IHDS and MMSE
to screen for HIV dementia in the same group of participants in
order to compare the effectiveness of both tools. The results
showed that the accuracy of the IHDS was superior to that of the
other scale (84%, compared to 72%). Ganasen et al.11 found that the
sensitivity and speciﬁcity of the IHDS were both 80% in South
Africa. Mishra’s research indicated that the IHDS, with a sensitivity
and speciﬁcity of 76.90% and 65% respectively, could be used to
effectively screen for HAND in India. The results of the present
study show that the IHDS’s area under the curve is 0.772, while the
MMSE’s is 0.687.
Our research team performed a meta-analysis of the IHDS in
2012 and found that the summary ROC (SROC) curve drawn from
HAND data demonstrates a sensitivity of 0.90 [95% conﬁdence
interval (CI), 0.88–0.91] and overall speciﬁcity of 0.96 (95% CI,
0.95–0.97) for the IHDS. The scale’s Q*-value is 0.9195, and its
diagnostic odds ratio (DOR) is 162.28 (95% CI, 91.82–286.81).12 A
comparison of the ROC curves of both scales in the present study
also prompted the conclusion that the IHDS is more effective in
screening for HAND than is the MMSE. At the IHDS’s optimal cut-
off, the sensitivity and speciﬁcity of the scale are 73.7% and 69.7%,
respectively, whereas the MMSE’s are 47.4% and 88.4%.
Currently, the international community recommends a diag-
nostic cut-off of 10 points on the IHDS. However, this does not
include the inﬂuence of educational level, age, ethnicity, and other
sociocultural factors in its deﬁnition. Cultural differences in terms
of educational attainment that exist in different geographical areas
may affect the IHDS’s diagnostic cut-offs. Several studies
performed in underdeveloped regions demonstrated that HIV-
positive individuals who scored lower on the IHDS also had lower
educational levels, indicating that IHDS scores may be related to
the degree of educational attainment. If the cut-off score of 10
points is applied to HAND diagnoses in underdeveloped regions,
false positives may increase. The emergence of false positives will
elevate the rate of misdiagnosis and waste limited health
resources.
Table 4 depicts the signiﬁcantly different IHDS scores we
observed among individuals with different levels of educational
attainment (t = -5.754, P = 0.00). Drenna13 also found that educa-
tional level inﬂuenced diagnostic results in India. In addition, the
IHDS has been known to not be as sensitive in screening for HANDTable 4
IHDS Scores for AIDS patients with different characteristics
Characteristics Score t value P value
Age
<60 years 8.13  2.05 3.96 0.000
60 years 7.05  1.32
Gender
Male 7.86  1.96 -1.350 0.178
Female 8.23  2.05
Ethnicity
Han Chinese 8.15  2.01 2.386 0.018
Zhuang minorities 7.45  1.86
Education
Did not graduate from junior high school 7.33  1.91 -5.754 0.000
Did graduate from junior high school 8.76  1.83
Smoking
Smoker 7.75  2.14 0.978 0.329
Non-smoker 8.05  1.95
Drinking
drinker 8.02  2.08 0.151 0.880
Non-drinker 7.97  1.98in populations with middle or high educational levels. If these
individuals were assessed with the IHDS on a cutoff of 10 points,
the diagnoses may lead to more false negatives. Thus, different
IHDS diagnostic cut-offs should be developed for regions with
different cultural and educational backgrounds. The Guangxi
Zhuang minority autonomous region, located in a remote
mountainous area where poverty is widespread, is known to be
socio-economically underdeveloped, as well as having poor
natural environmental conditions and limited educational and
sociocultural attainment. In the Guangxi Zhuang minority
autonomous region, which is ranked second in China in incidence
of AIDS, few individuals infected with HIV receive much in the way
of schooling.
Our study collected data on 230 cases of HIV-seropositive
individuals, of whom only 49 had a high school or higher level of
education, accounting for approximately 21.30% of all cases. As a
result, the diagnostic cut-off (7.25) was ascertained to be lower
than the internationally recommended standard of 10 points. In
other words, our study demonstrates the need for exploring not
one but a range of diagnostic cut-offs for the IHDS, which suggests
that different diagnostic values should be recommended for
various populations or groups of individuals with different
educational and sociocultural backgrounds. However, which level
of educational attainment corresponds with which diagnostic cut-
off remains to be determined.
5. Conclusion
In the present study, a full neuropsychological evaluation of the
gold standard was conducted to identify the incidence/prevalence
of HAND in a region of Southern China where residents had limited
formal schooling. Additionally, we sought to locate the optimal
cut-off value on the scale using ROC curves. Given our Youden
index, cut-off point, and sensitivity and speciﬁcity values, our
results verify the scale’s efﬁcacy and feasibility for screening for
HAND in underdeveloped regions of China with less educated
populations.
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